Treatment of Giant Cell Arteritis
- PMID: 36963826
- DOI: 10.1097/IIO.0000000000000470
Treatment of Giant Cell Arteritis
Conflict of interest statement
The authors declare that they have no conflicts of interest to disclose.
References
-
- Hoffman GS. Giant cell arteritis. Ann Intern Med. 2016;165:ITC65–ITC80.
-
- Almarzouqi SJ, Morgan ML, Lee AG. Treatment of giant cell arteritis. Curr Opin Ophthalmol. 2015;26:469–475.
-
- Eberhardt RT, Dhadly M. Giant cell arteritis: diagnosis, management, and cardiovascular implications. Cardiol Rev. 2007;15:55–61.
-
- Liu GT, Glaser JS, Schatz NJ, et al. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 1994;101:1779–1785.
-
- Mazlumzadeh M, Hunder GG, Easley KA, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 2006;54:3310–3318.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
